Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:582106rdf:typepubmed:Citationlld:pubmed
pubmed-article:582106lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:582106lifeskim:mentionsumls-concept:C0023726lld:lifeskim
pubmed-article:582106lifeskim:mentionsumls-concept:C0683149lld:lifeskim
pubmed-article:582106lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:582106lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:582106pubmed:issue1lld:pubmed
pubmed-article:582106pubmed:dateCreated1979-7-25lld:pubmed
pubmed-article:582106pubmed:abstractTextThe pharmacokinetics of lincomycin (Albiotic) were studied in ten healthy male and female volunteers after administration of 1 X 3 g and 2 X 3 g lincomycin i.v., respectively, infused over 60 min. After discontinuing the infusion a mean serum value of lincomycin of 97.5 microgram/ml was measurable. 5 h later the mean serum values were 13.5 microgram/ml and 24 h later 1.6 microgram/ml. After 24 h 72.5% of the drug had been eliminated in the urine of 4 volunteers. The mean serum half-life was 286.3 min with the one-compartment model. The volume of distribution was 78.7 l with the one-compartment model and 25.9 l with the two-compartment model. The area under the curve has the value of 14 805.39 microgram . min . ml-1 and 44 418.9 microgram . min. ml-1 with the one- and two-compartment model, respectively. The mean values for the total renal clearance with the two models were 204.8 and 75.5 ml/min. The importance of high-dose therapy with lincomycin is discussed with respect to the tissue penetration of the substance and possible bactericidal effects, whereas lincomycin in general only acts bacteriostatic.lld:pubmed
pubmed-article:582106pubmed:languagegerlld:pubmed
pubmed-article:582106pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:582106pubmed:citationSubsetIMlld:pubmed
pubmed-article:582106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:582106pubmed:statusMEDLINElld:pubmed
pubmed-article:582106pubmed:issn0004-4172lld:pubmed
pubmed-article:582106pubmed:authorpubmed-author:AdamDDlld:pubmed
pubmed-article:582106pubmed:authorpubmed-author:PätzoldJJlld:pubmed
pubmed-article:582106pubmed:issnTypePrintlld:pubmed
pubmed-article:582106pubmed:volume29lld:pubmed
pubmed-article:582106pubmed:ownerNLMlld:pubmed
pubmed-article:582106pubmed:authorsCompleteYlld:pubmed
pubmed-article:582106pubmed:pagination130-4lld:pubmed
pubmed-article:582106pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-H...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-I...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-F...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-M...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-K...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-A...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-M...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-L...lld:pubmed
pubmed-article:582106pubmed:meshHeadingpubmed-meshheading:582106-H...lld:pubmed
pubmed-article:582106pubmed:year1979lld:pubmed
pubmed-article:582106pubmed:articleTitle[Serum concentration and kinetics after i.v.-infusion of 3 g lincomycin (author's transl)].lld:pubmed
pubmed-article:582106pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:582106pubmed:publicationTypeEnglish Abstractlld:pubmed